Switch to:

Corvus Pharmaceuticals EBIT per Share

: $-1.60 (TTM As of Jun. 2020)
View and export this data going back to 2016. Start your Free Trial

Corvus Pharmaceuticals's EBIT per Share for the three months ended in Jun. 2020 was $-0.37. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $-1.60.

During the past 3 years, the average EBIT per Share Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

NAS:CRVS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36.5   Med: -11.75   Max: 13
Current: 13
-36.5
13

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Corvus Pharmaceuticals was 13.00% per year. The lowest was -36.50% per year. And the median was -11.75% per year.

NAS:CRVS's 3-Year EBIT Growth Rate is not ranked
in the Biotechnology industry.

( Industry Median: 4.65 vs. NAS:CRVS: 13.00 )

Corvus Pharmaceuticals's EBIT for the three months ended in Jun. 2020 was $-10.77 Mil.

Corvus Pharmaceuticals EBIT per Share Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Corvus Pharmaceuticals Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EBIT per Share Premium Member Only -0.68 -2.40 -2.76 -1.79 -1.67

Corvus Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EBIT per Share Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.46 -0.39 -0.39 -0.45 -0.37

Corvus Pharmaceuticals EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Corvus Pharmaceuticals's EBIT per Share for the fiscal year that ended in Dec. 2019 is calculated as

EBIT per Share(A: Dec. 2019 )
=EBIT/Shares Outstanding (Diluted Average)
=-48.854/29.350
=-1.66

Corvus Pharmaceuticals's EBIT per Share for the quarter that ended in Jun. 2020 is calculated as

EBIT per Share(Q: Jun. 2020 )
=EBIT/Shares Outstanding (Diluted Average)
=-10.767/29.428
=-0.37

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2020 was -0.392 (Sep. 2019 ) + -0.389 (Dec. 2019 ) + -0.451 (Mar. 2020 ) + -0.366 (Jun. 2020 ) = $-1.60

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Corvus Pharmaceuticals  (NAS:CRVS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Corvus Pharmaceuticals EBIT per Share Related Terms

Corvus Pharmaceuticals EBIT per Share Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)